Mandate

Vinge has advised Snusbolaget in connection with the acquisition of Northerner

October 01, 2019 M&A

Vinge has advised Snusbolaget Norden Holding AB in connection with the acquisition of Northerner Scandinavia AB

The E‑trading company Snusbolaget sells snus and tobacco‑free nicotine pouches from other suppliers online. In 2018, the company had a turnover of SEK 500 million and grew by 65 per cent. In 2018, Northerner had a turnover of approximately SEK 100 million. Following the acquisition, the company will be called Haypp Group and will have approximately 500,000 customers in 80 countries in Europe, Asia and the United States with an anticipated turnover in 2019 of almost SEK 1 billion.


Vinge’s team consisted of partner Kristian Ford together with, among others, associates Niklas Törnell, Sophia Reutercrona, Tilda Hall, Fredrik Christiansson, Jack Bengtsson and Emelie Svensäter Jerntorp.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026